Jaguar Health (JAGX) Equity Average (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Equity Average data on file, last reported at -$17.2 million in Q1 2026.

• Equity Average for Q1 2026 came in at -$17.2 million, down 570.23% year-over-year; the trailing twelve-month figure through Mar 2026 was -$17.2 million (down 570.23% YoY), and the FY2025 annual result was -$6.1 million, down 207.05% from the prior year.
• Equity Average retreated to -$17.2 million in Q1 2026 per JAGX's latest filing, from -$7.2 million in the prior quarter.
• Over five years, Equity Average peaked at $14.8 million in Q3 2024 and troughed at -$17.2 million in Q1 2026.
• A 5-year average of $4.3 million and a median of $3.9 million in 2025 frame the typical range for Equity Average.
• The sharpest annual moves came in 2024 and 2026: Equity Average jumped 309.54% in 2024, then tumbled 570.23% in 2026.
• A 5-year view of Equity Average shows it stood at $1.1 million in 2022, then surged by 181.83% to $3.2 million in 2023, then soared by 210.33% to $9.8 million in 2024, then tumbled by 173.14% to -$7.2 million in 2025, then tumbled by 140.35% to -$17.2 million in 2026.
• Business Quant data shows JAGX's Equity Average at -$17.2 million in Q1 2026, -$7.2 million in Q4 2025, and $5.6 million in Q3 2025.